RPS27A and metabolic dysfunction-associated steatotic liver disease: The significant top five PPI pathways of DEmRNAs were ubiquitin-mediated proteolysis, non-alcoholic fatty liver disease, Parkinson’s disease, Huntington’s disease, and citrate cycle (Figure 1B and Supplementary Table S3).